WHO ICTRP trial

A clinical trial for the treatment of severe non-proliferative diabetic…

ChiCTR2500115035 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500115035
Public title A clinical trial for the treatment of severe non-proliferative diabetic retinopathy with microinvasive pars plana vitrectomy and pan retinal photocoagulation
Scientific title A clinical trial for the treatment of severe non-proliferative diabetic retinopathy with microinvasive pars plana vitrectomy and pan retinal photocoagulation
Primary sponsor Huashan Hospital Fudan University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Countries China
Conditions severe non-proliferative diabetic retinopathy
Interventions Experimental Group:Pars plana vitrectomy Panretinal Photocoagulation;control group:Panretinal Photocoagulation
Registration date Dec 22, 2025
Target size Experimental Group:59;control group:59
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations